anti tcf3 Search Results


93
TargetMol abbreviations he2a pbx1 human e2a pbx1
Abbreviations He2a Pbx1 Human E2a Pbx1, supplied by TargetMol, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+tcf3/Anti-TCF3+Antibody/pm38385270-564-119-179
Average 93 stars, based on 1 article reviews
abbreviations he2a pbx1 human e2a pbx1 - by Bioz Stars, 2026-10
93/100 stars
  Buy from Supplier

92
Atlas Antibodies tcf3
Figure 1. Quantitative and qualitative assessment of <t>TCF3</t> expression in megakaryocytes of MPN (ET/PV = 68, MF = 34) and control bone marrow trephines (n = 71). (A–E) Immunohistochemical staining showing TCF3 in bone marrow trephines of normal marrow and MPN subtypes. Black arrows indicate examples of TCF3-positive and white arrows TCF3-negative megakaryocytes. Positive erythroid, granulocyte and lymphoid cells are present in all cases. A) control bone marrow (x600); B) ET (x600); C) PV (x600); D) MF with distorted TCF3-negative megakaryocytes adjacent to trabecular bone (x400); E) MF that arose secondary to preceding ET. The interstitial megakaryocytes are positive and have a morphological appearance as seen in B). The TCF3-negative megakaryocytes are angulated with pyknotic nuclear chromatin, a feature of MF (x400). (DAB substrate; hematoxylin counterstain.) F) percentage of megakaryocytes expressing TCF3 in control, ET/PV and MF patients (Kruskal–Wallis one-way ANOVA analysis followed by Benjamini–Hochberg adjustment). Data shown as the mean ±95% confidence interval. *padj < 0.05, **padj < 0.01, ***padj < 0.001, ****padj < 0.0001.
Tcf3, supplied by Atlas Antibodies, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+tcf3/Anti-TCF3/pm38303515-36-10-11
Average 92 stars, based on 1 article reviews
tcf3 - by Bioz Stars, 2026-10
92/100 stars
  Buy from Supplier

93
Boster Bio chx10
Figure 1. Quantitative and qualitative assessment of <t>TCF3</t> expression in megakaryocytes of MPN (ET/PV = 68, MF = 34) and control bone marrow trephines (n = 71). (A–E) Immunohistochemical staining showing TCF3 in bone marrow trephines of normal marrow and MPN subtypes. Black arrows indicate examples of TCF3-positive and white arrows TCF3-negative megakaryocytes. Positive erythroid, granulocyte and lymphoid cells are present in all cases. A) control bone marrow (x600); B) ET (x600); C) PV (x600); D) MF with distorted TCF3-negative megakaryocytes adjacent to trabecular bone (x400); E) MF that arose secondary to preceding ET. The interstitial megakaryocytes are positive and have a morphological appearance as seen in B). The TCF3-negative megakaryocytes are angulated with pyknotic nuclear chromatin, a feature of MF (x400). (DAB substrate; hematoxylin counterstain.) F) percentage of megakaryocytes expressing TCF3 in control, ET/PV and MF patients (Kruskal–Wallis one-way ANOVA analysis followed by Benjamini–Hochberg adjustment). Data shown as the mean ±95% confidence interval. *padj < 0.05, **padj < 0.01, ***padj < 0.001, ****padj < 0.0001.
Chx10, supplied by Boster Bio, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+tcf3/Anti-CHX10+Rabbit+Monoclonal+Antibody/pmc11947540-48-8-12
Average 93 stars, based on 1 article reviews
chx10 - by Bioz Stars, 2026-10
93/100 stars
  Buy from Supplier

90
Bioworld Antibodies anti-tcf-3
Figure 1. Quantitative and qualitative assessment of <t>TCF3</t> expression in megakaryocytes of MPN (ET/PV = 68, MF = 34) and control bone marrow trephines (n = 71). (A–E) Immunohistochemical staining showing TCF3 in bone marrow trephines of normal marrow and MPN subtypes. Black arrows indicate examples of TCF3-positive and white arrows TCF3-negative megakaryocytes. Positive erythroid, granulocyte and lymphoid cells are present in all cases. A) control bone marrow (x600); B) ET (x600); C) PV (x600); D) MF with distorted TCF3-negative megakaryocytes adjacent to trabecular bone (x400); E) MF that arose secondary to preceding ET. The interstitial megakaryocytes are positive and have a morphological appearance as seen in B). The TCF3-negative megakaryocytes are angulated with pyknotic nuclear chromatin, a feature of MF (x400). (DAB substrate; hematoxylin counterstain.) F) percentage of megakaryocytes expressing TCF3 in control, ET/PV and MF patients (Kruskal–Wallis one-way ANOVA analysis followed by Benjamini–Hochberg adjustment). Data shown as the mean ±95% confidence interval. *padj < 0.05, **padj < 0.01, ***padj < 0.001, ****padj < 0.0001.
Anti Tcf 3, supplied by Bioworld Antibodies, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+tcf3/anti+tcf+3/pm19879238-75-10-12
Average 90 stars, based on 1 article reviews
anti-tcf-3 - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

N/A
Recombinant Mouse Antibody specifically binds to Human TCF3, expressed in Chinese Hamster Ovary cells(CHO).Antibody assay: Western blot; Enzyme-linked Immunosorbent Assay; Immunohistochemistry; Functional StudyStore at -20°C. Open under aseptic conditions.http://www.creativebiolabs.net/Rcombinant-Anti-Human-TCF3-Antibody-11460.htm
  Buy from Supplier

N/A
TCF3 / E2A Goat anti-Human Polyclonal (Internal) (Unconjugated) Antibody, (50 µg)
  Buy from Supplier

N/A
Rabbit Anti-TCF3 (C-term) Antibody, 400 µl
  Buy from Supplier

N/A
Rabbit anti-Human Phospho-TCF3 Polyclonal Antibody
  Buy from Supplier

N/A
The TCF3 gene, also called E2A, encodes 2 basic helix-loop-helix (bHLH) transcription factors, E12 and E47, through alternative splicing. E12 and E47 are involved in regulation of immunoglobulin gene expression (Bain et al., 1994 [PubMed
  Buy from Supplier

N/A
Goat Anti-Human TCF3 / ITF1, (internal region)
  Buy from Supplier

N/A
Goat polyclonal to TCF3 / ITF1 (Biotin). Conjugation note: Biotin Application note: ELISA, WB, IHC Reactivity note: Human
  Buy from Supplier

Image Search Results


Figure 1. Quantitative and qualitative assessment of TCF3 expression in megakaryocytes of MPN (ET/PV = 68, MF = 34) and control bone marrow trephines (n = 71). (A–E) Immunohistochemical staining showing TCF3 in bone marrow trephines of normal marrow and MPN subtypes. Black arrows indicate examples of TCF3-positive and white arrows TCF3-negative megakaryocytes. Positive erythroid, granulocyte and lymphoid cells are present in all cases. A) control bone marrow (x600); B) ET (x600); C) PV (x600); D) MF with distorted TCF3-negative megakaryocytes adjacent to trabecular bone (x400); E) MF that arose secondary to preceding ET. The interstitial megakaryocytes are positive and have a morphological appearance as seen in B). The TCF3-negative megakaryocytes are angulated with pyknotic nuclear chromatin, a feature of MF (x400). (DAB substrate; hematoxylin counterstain.) F) percentage of megakaryocytes expressing TCF3 in control, ET/PV and MF patients (Kruskal–Wallis one-way ANOVA analysis followed by Benjamini–Hochberg adjustment). Data shown as the mean ±95% confidence interval. *padj < 0.05, **padj < 0.01, ***padj < 0.001, ****padj < 0.0001.

Journal: Platelets

Article Title: Transcription factor 3 is dysregulated in megakaryocytes in myelofibrosis.

doi: 10.1080/09537104.2024.2304173

Figure Lengend Snippet: Figure 1. Quantitative and qualitative assessment of TCF3 expression in megakaryocytes of MPN (ET/PV = 68, MF = 34) and control bone marrow trephines (n = 71). (A–E) Immunohistochemical staining showing TCF3 in bone marrow trephines of normal marrow and MPN subtypes. Black arrows indicate examples of TCF3-positive and white arrows TCF3-negative megakaryocytes. Positive erythroid, granulocyte and lymphoid cells are present in all cases. A) control bone marrow (x600); B) ET (x600); C) PV (x600); D) MF with distorted TCF3-negative megakaryocytes adjacent to trabecular bone (x400); E) MF that arose secondary to preceding ET. The interstitial megakaryocytes are positive and have a morphological appearance as seen in B). The TCF3-negative megakaryocytes are angulated with pyknotic nuclear chromatin, a feature of MF (x400). (DAB substrate; hematoxylin counterstain.) F) percentage of megakaryocytes expressing TCF3 in control, ET/PV and MF patients (Kruskal–Wallis one-way ANOVA analysis followed by Benjamini–Hochberg adjustment). Data shown as the mean ±95% confidence interval. *padj < 0.05, **padj < 0.01, ***padj < 0.001, ****padj < 0.0001.

Article Snippet: Sections were cut at 3 μm and then stained for TCF3 (Atlas Antibodies, Stockholm, Sweden).

Techniques: Expressing, Control, Immunohistochemical staining, Staining

Figure 2. Normalized counts of A) TCF3 and direct targets B) CDKN1A, C) GFI1B and D) AURKA in control (n = 10), ET/PV (n = 48) and MF (n = 26) patients. Normalized counts were analyzed using a one-way ANOVA followed by Benjamini–Hochberg adjustment. Data shown as mean ± 95% confidence interval. *padj < 0.05, **padj < 0.01, ***padj < 0.001, ****padj < 0.0001.

Journal: Platelets

Article Title: Transcription factor 3 is dysregulated in megakaryocytes in myelofibrosis.

doi: 10.1080/09537104.2024.2304173

Figure Lengend Snippet: Figure 2. Normalized counts of A) TCF3 and direct targets B) CDKN1A, C) GFI1B and D) AURKA in control (n = 10), ET/PV (n = 48) and MF (n = 26) patients. Normalized counts were analyzed using a one-way ANOVA followed by Benjamini–Hochberg adjustment. Data shown as mean ± 95% confidence interval. *padj < 0.05, **padj < 0.01, ***padj < 0.001, ****padj < 0.0001.

Article Snippet: Sections were cut at 3 μm and then stained for TCF3 (Atlas Antibodies, Stockholm, Sweden).

Techniques: Control

Figure 3. Genes involved in the downstream effects of TCF3 inhibition. Network activation and inhibition was stratified to a z-score below −2 and above 2. Networks fulfilling the “bias” criteria were excluded. Minimum network-bias-corrected p-value of 10−4. Genes in orange are predicted to be activated and in blue are predicted to be inhibited. Red indicates genes that have increased transcript expression in platelets from patients with ET/PV (n = 48) and MF (n = 26) patients.

Journal: Platelets

Article Title: Transcription factor 3 is dysregulated in megakaryocytes in myelofibrosis.

doi: 10.1080/09537104.2024.2304173

Figure Lengend Snippet: Figure 3. Genes involved in the downstream effects of TCF3 inhibition. Network activation and inhibition was stratified to a z-score below −2 and above 2. Networks fulfilling the “bias” criteria were excluded. Minimum network-bias-corrected p-value of 10−4. Genes in orange are predicted to be activated and in blue are predicted to be inhibited. Red indicates genes that have increased transcript expression in platelets from patients with ET/PV (n = 48) and MF (n = 26) patients.

Article Snippet: Sections were cut at 3 μm and then stained for TCF3 (Atlas Antibodies, Stockholm, Sweden).

Techniques: Inhibition, Activation Assay, Expressing